|  | 


New strain of Covid-19 has yet to be detected in India, says VK Paul, member of Niti Aayog – health


Dr VK Paul, a member of the government think tank Niti Aayog, said on Tuesday that the new strain of the coronavirus that has been spreading rapidly in the UK has yet to be detected in India. Speaking at a Health Ministry press conference, Dr. Paul also said there is no cause for concern and asked people not to panic and stay tuned for the virus. “There is no cause for concern, there is no need to panic, as for now. We have to be vigilant, ”he said.

While the new strain of infection has increased the transmissibility of the virus, the severity of the disease and the fatality are not affected by this mutation, said Dr. Paul.

“The new strain of Covid-19 in the UK has increased transmissibility. This mutation does not affect the severity of the disease. Lethality is not affected by this mutation, “he added.

When asked about the impact of this new mutation on vaccines being developed in India, he said that the new mutation currently does not affect the potential of emerging vaccines in India and elsewhere. “As of now, it has no impact on the potential of emerging vaccines that are being developed in our country and are available in other countries,” he said.

Health Secretary Rajesh Bhushan noted that India’s recovery rate has now reached 95 percent and the number of active Covid-19 cases is less than three lakhs. “It is after almost 5.5 months, we have less than 3 lakh of active Covid-19 cases in the country. Currently, active cases are less than 3% of all cases, “he added. Bhushan also said that the daily average of new cases for the past seven weeks has decreased.

India suspended air travel from England on Monday after cases spiked in the UK due to a new coronavirus mutation. When asked about passengers already arriving in India, Bhushan said that Covid-19 RT-PCR testing is mandatory for UK passengers at airports.

He also said that genome sequencing is being done in designated laboratories of the Department of Biotechnology, the Indian Council for Medical Research (ICMR), the Council for Scientific and Industrial Research (CSIR) and the National Center for Disease Control (NCDC). to observe the presence of the new mutation.

Hindustan Times